Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
ND
NORDIX DNA ApS
aktivCVR 36908130AnpartsselskabÅhaven 13, 9900 FrederikshavnEngroshandel med læge- og hospitalsartikler
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 07 Oct 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Not disclosed—
Not disclosed
Operating profit
DKK -9k
Latest period
Source details
Source: dk-regnskabsdata-live-36908130-1791331679261
Document: dk-regnskabsdata-36908130-AZ2YQdHmIfGsIONvTTul-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: c0
Unit: u0
Net result
DKK -9k
Latest period
Source details
Source: dk-regnskabsdata-live-36908130-1791331679261
Document: dk-regnskabsdata-36908130-AZ2YQdHmIfGsIONvTTul-1
XBRL: fsa:ProfitLoss
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: c0
Unit: u0
Equity
DKK -1.5k
Equity ratio: -1.5%
Source details
Source: dk-regnskabsdata-live-36908130-1791331679261
Document: dk-regnskabsdata-36908130-AZ2YQdHmIfGsIONvTTul-1
XBRL: fsa:Equity
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: c3
Unit: u0
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK 74 |
| 2023 | — | DKK 8 |
| 2024 | — | DKK -98.8k |
| 2025 | — | DKK -9k |